Neuberger, Elmo W. I.; Sontag, Stephanie; Brahmer, Alexandra et al.
Physical activity specifically evokes release of cell-free DNA from granulocytes thereby affecting liquid biopsyCLINICAL EPIGENETICS. Bd. 14. H. 1. 2022
Woelfinger, P.; Hauptrock, B.; Kriege, O. et al.
Pre-transplant platelet-to- lymphocyte ratio predicts outcome after allogeneic hematopoietic stem cell transplantationSCIENTIFIC REPORTS. Bd. 12. H. 1. 2022
Al Hariri, Mohammad; Munder, Markus; Lisch, Walter et al.
Prevalence of corneal findings and their interrelation with hematological findings in monoclonal gammopathyPLOS ONE. Bd. 17. H. 10. 2022
Albinger, Nawid; Pfeifer, Rita; Nitsche, Marcus et al.
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemiaBLOOD CANCER JOURNAL. Bd. 12. H. 4. 2022
Kotrova, Michaela; Koopmann, Johannes; Trautmann, Heiko et al.
Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methodsBLOOD ADVANCES. Bd. 6. H. 10. 2022 S. 3006-3010
Koehler, Friederike; Kessler, Jens; Stoffel, Martin et al.
Psychoneuroendocrinological effects of music therapy versus mindfulness in palliative care: results from the 'Song of Life' randomized controlled trialSUPPORTIVE CARE IN CANCER. Bd. 30. H. 1. 2022 S. 625-634
Hess, Georg; Dreyling, Martin; Oberic, Lucie et al.
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review studyBRITISH JOURNAL OF HAEMATOLOGY. 2022
Lommatzsch, Marek; Suhling, Hendrik; Korn, Stephanie et al.
Safety of combining biologics in severe asthma: Asthma-related and unrelated combinationsALLERGY. Bd. 77. H. 9. 2022 S. 2839-2843
Tilch, Marie-Kristin; Robak, Tadeusz; Ghiggi, Chiara et al.
Safety of the Anti-CD19 antibody Tafasitamab in Long Term Responders from A Phase II Trial for Relapsed LymphomaCLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Bd. 22. H. 4. 2022 S. 270-275
Panse, Jens; Toelle, Daniela; Fiegle, Eva et al.
Scheduled removal of central venous catheters (CVC) to prevent CVC-related bloodstream infections in patients with hematological disease or autologous stem cell transplantation: a registry-based randomized simulation-studyANNALS OF HEMATOLOGY. Bd. 101. H. 10. 2022 S. 2317-2324